Because the adult mammalian central nervous system has only limited intrinsic capacity to regenerate connections after injury, due to factors both intrinsic and extrinsic to the mature neuron…
Category: News
Survival and regeneration of retinal cells after injury promoted by dental pulp stem cells
Researchers at the University of Birmingham, UK, led by Dr. Ben Scheven, Dr.
Doxycycline Fails to Slow Diabetic Retinopathy Progression
Doxycycline does not appear to improve retinal function or slow diabetic retinopathy progression in patients with mild to moderate nonproliferative diabetic retinopathy (NPDR), according to results from a proof-of-concept clinical trial. Reuters Heal…
Scientists regrow human corneas to restore vision
In one of the first known examples of making tissue from an adult-derived human stem cell, scientists have found a way to enhance regrowth of corneal tissue to restore vision.
Anti-VEGF Improves Quality of Life in Macular Degeneration
When patients’ vision improved when receiving ranibizumab, their quality of life improved too. Medscape Medical News
Limbal stem cells, identified with new marker, could reverse a leading cause of blindness
Boston researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find limbal stem cells.
Implanted Wireless Device Monitors Intraocular Pressure
A wireless device that was implanted in the eye of a glaucoma patient and monitored for well over a year measured intraocular pressure safely and accurately, researchers report. Reuters Health Information
Researchers discover a way to restore corneal surface
A Boston-based scientific collaborative, led by Harvard Stem Cell Institute researchers, has discovered a way to collect the best cell type for regenerating a damaged cornea-the clear membrane that covers the pupil and directs light into the back of th…
Allergan receives FDA approval for Ozurdex® treatment option for use in certain patients with diabetic macular edema
Allergan, Inc., has announced that the U.S. Food and Drug Administration (FDA) has approved OZURDEX® as a new treatment option for diabetic macular edema (DME) in adult patients who have an…
Research may help prevent eye injuries among soldiers
Researchers at UTSA are discovering that the current protective eyewear used by our U.S. armed forces might not be adequate to protect soldiers exposed to explosive blasts.
Focal choroidal excavation’s coexistence with other choroidal diseases impairs vision
Focal choroidal excavation appears to be relatively common and can have a detrimental effect on vision, a study of Korean patients suggests.
Reticular drusen linked to AMD progression
Four percent of individuals aged 49 years and above will develop reticular drusen over 15 years of follow-up, Australian study findings suggest, with the incidence higher in those with age-related macular degeneration risk factors.
Vitreous anatomic features characterised
Researchers have found a direct anteroposterior connection between the retrolental and premacular and preoptic spaces that exits in young adults before the occurrence of vitreous degeneration.
A 32-Year-Old Woman With Decreased Vision in Her Left Eye
A 32-year-old woman with a known brain tumor has decreased vision in her left eye. What is your differential diagnosis? Medscape Ophthalmology
No Change in Retinopathy in Diabetes 2 Years After Surgery
Two years after diabetic patients undergo bariatric surgery, diabetic retinopathy has neither worsened nor improved, data from STAMPEDE show. Regular eye exams are still important, investigators stress. Medscape Medical News
BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma
BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FD…
FDA OKs Ozurdex for Some With Diabetic Macular Edema
The new indication is for treatment of adults with diabetic macular edema who have an artificial lens implant (pseudophakic) or who are scheduled for cataract surgery (phakic). FDA Approvals
FDA OKs Implant for Diabetic Eye Disease
(MedPage Today) — The FDA has approved an intravitreal steroid implant for diabetic macular edema patients who already have a lens implant or who are going to have cataract surgery.
EU Panel OKs Aflibercept for Diabetic Macular Edema (Eylea)
The company marketing the drug in the United States has asked the US Food and Drug Administration to add this indication as well. International Approvals
Practice-Changing Highlights in Glaucoma
Find out whether you are up-to-date with the latest glaucoma surgery enhancements. Medscape Ophthalmology